Professional Medical Education Excellence Pharma


Published on

Report Summary for "Professional Medical Education Excellence: Structures, Resources, Services & Performance Levels to Optimize Pharmaceutical Education Groups." Contact me to learn how to access the full report.

  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Professional Medical Education Excellence Pharma

  1. 1. Professional Medical Education Excellence:Structures, Resources, Services & Performance Levels to Optimize Pharmaceutical Education Groups 1 Copyright© Best Practices®, LLC
  2. 2. TABLE OF CONTENTSI. Executive Summary Business Issue & Objectives, p.4 Project Blueprint, p.5 Key Findings, p.6-8 Participants, p.9-10 Medical Education Landscape, p.11II. Participant Overview Information, p.12-15III. Organizational Fit & Geographic Focus, p.16-28IV. Staffing Benchmarks & Program Trends, p.29-45V. Roles for Key Activities & Program Deployment, p.46-60VI. Budget Benchmarks & Allocation Trends, p.61-74VII. Trends & Directions, p. 75-83VIII. About Best Practices, LLC, p.84-85
  3. 3. Business Issue & ObjectivesMany in the Pharma sector need evidence-based medical education staffing benchmarksto determine if their medical education group is sufficiently staffed and funded or shouldadd resources, shrink resources or shift resources. Objectives: Determine the structure and activities of Medical Education function. Benchmark professional Medical Education staffing. Identify Medical Education services and role of Medical Education group in key activities (thought leaders, professional societies, education programs and compliance). Benchmark Medical Education resources, investment allocation and budget allocation by region and program type. Determine the future trends and direction in Medical Education for field-based medical educators, technological changes and spending changes. Field Research & Insight Development: • Results based on initial survey INFORM INFORM Optimize Medical responses from 35 pharma and medical Education Capabilities, device organizations Efficiency & • Conducted in-depth interviews with four Effectiveness industry leaders 3 Copyright© Best Practices®, LLC
  4. 4. Key Findings: MedEd Technology and Performance MeasurementMedical Education technology and performance measurement Technology-based programs will increase in the next two years in both pharma and device sectors. However, 61 percent of pharma participants project increases of 10 percent or more, while device participants foresee an explosion with 58 percent anticipating more than 30 percent in growth. Another difference between both segments in terms of technology is the adoption of iPads/tablets into the education environment. Pharma’s investing in iPads/tablets will represent, on average, 16 percent of their technology budget over the next two years. In contrast, iPads/tablets will represent 29 percent of device technology budgets in the device sector, according to respondents. One key reason for this difference is that the iPad/tablet technology is a good fit for the animations and simulations that complement device training. Performance measurement in Medical Education is a sore point for many, with no one voicing absolute satisfaction with current approaches in either pharma or device segments. Common metrics used to show value are programs conducted, attendees, and percentage of repeat attendees in different courses. Post-program surveys are also common, although many don’t view them as reliable measures. Market adoption of a therapy can be a useful measure of training, but it is best used in geographies where there is low penetration of the treatment. 4 Copyright© Best Practices®, LLC
  5. 5. Study Draws Robust Response from Pharma and Device SectorsForty medical education executives and leaders from across 35 pharmaceutical and medicaldevices companies participated in this study. Participants included 26 leaders from 25 pharmacompanies and 14 medical education leaders from 10 medical device firms. Survey Only Participating Companies 5 Copyright© Best Practices®, LLC
  6. 6. Professional Medical Education Excellence: Organizational Fit & Geographic Focus 6 Copyright© Best Practices®, LLC
  7. 7. Pharma Medical Education Professional Fit is with Med AffairsAfter years of transitioning from other functions such as marketing, Medical Education inpharma has become firmly nestled in medical affairs. The association with medical affairs hasreduced criticism of pharma-funded CME programs. Pharma MedEd groups are now morediligent about following guidelines regarding CME content development and delivery. Medical Education Professional Fit: Please indicate where the professional medical education function fits professionally at your company or unit. A free- Part of standing or larger independent Marketing group or group, 4% function, 4% Part of larger Medical Affairs group, 92% Pharmaceutical Segment N=26 7 Copyright© Best Practices®, LLC
  8. 8. Professional Medical Education Excellence: Staffing Benchmarks & Program Trends 8 Copyright© Best Practices®, LLC
  9. 9. Emerging Markets Lacking FTEs from Pharma SectorNorth America and Europe remain the main home to Medical Education FTEs in thepharmaceutical sector. However, resources will only increase in emerging markets suchas China and India as those areas represent future growth for the industry. Please estimate the relative percent allocation of total medical education FTEs working to support each region. The total should sum to the total global FTEs. Pharmaceutical Segment 100% 100% Max Mean Min 76.30% 20% 20% 20% 20% 14.80% 3.30% 2.40% 1.90% 1.40% 0% 0% 0% 0% 0% 0% North America (US Europe Asia-Pacific Latin America Asia-Emerging Eastern Europe / Canada) (Japan, Australia, (Mexico, (China, India, New Zealand) Caribbean, Southeast Asia) N=19 Central & South America) 9 Copyright© Best Practices®, LLC
  10. 10. Pharma Relies More on Home Office MedEd Staff Both the pharma and device segments utilize field-based Medical Education staff but the pharma side is less engaged in their use (pharma avg. 16 percent vs. device avg. 30 percent). The difference is tied to device MedEd groups relying on field staff to train physicians in clinical settings to demonstrate safe and effective use of devices.Mix of Medical Education Employees: Estimate the percentage of medical education global employees in different home-office and field-based jobs/roles within your medical education organization. In-House Medical Field-Based Education Employees Employees Pharmaceutical Segment N=21 Max 100% 80% Field-Based 75th Percentile 100% 20% Employees, In-House Mean 84% 16% Medical 16% Median 100% 0% education 25th Percentile 80% 0% Employees, 84% Min 20% 0% In-House Medical Field-Based Medical Device Segment N=12 Education Employees Employees Max 100% 100% Field-Based 75th Percentile 90% 42.5% Employees, In-House Mean 69.8% 30.2% 30.2% Medical Median 77.5% 22.5% Education 25th Percentile 57.5% 10% Employees, Min 0% 0% 69.8% 10 Copyright© Best Practices®, LLC
  11. 11. Pharma Concentrates on CME Program TypesWhile the Medical Education groups of both device and pharma participants support both CMEand non-CME programs, pharma heavily favors CME programs while the device sector focusesmore on non-CME programs. Programs Supported By Professional Medical Education Group: Estimate the total number of programs supported by your medical education organization in the last fiscal year. # of CME # of Non-CME Total # of CME # of Non-CME Total Programs Programs Programs Programs Max 2500 2200 4000 Max 400 1250 1400 75th Percentile 438 24 578 75th Percentile 91 90 280 Mean 398 185 583 Mean 69 187 256 Median 50 5 65 Median 3 60 120 25th Percentile 6 0 16 25th Percentile 0 24 24 Min 0 0 2 Min* 0 3 6 Pharmaceutical Segment Medical Device Segment N=22 N=13 * 5 Med Dev organizations said they did no CME programs 11 Copyright© Best Practices®, LLC
  12. 12. Professional Medical Education Excellence:Roles for Key Activities & Program Deployment 12 Copyright© Best Practices®, LLC
  13. 13. Pharma MedEd Staff Play Active Role with SocietiesLike the device segment, pharma participants reflected an active role in all activitiesrelated to professional societies. Similarly, Medical Education staff are most involved ingrants for societies - more than 80 percent say they lead or are active in this activity. Professional Societies: Please note the roles played by your Medical Education function in conducting these key activities regarding Professional Societies. No Role Small Role Support Role Active Role Lead Role Total Active/ 4%4% Lead Role Provide grants to medical societies 4% 30% 57% for education 87% Sponsor presentations during 17% 9%9% 26% 39% 65% annual society meetings Serve as key liaison between company and medical society senior 13% 9% 26% 35% 17% 52% leadership Develop relations with professional 52% 13% 35% 39% 13% medical societies N=23 Pharmaceutical Segment 13 Copyright© Best Practices®, LLC
  14. 14. Pharma MedEd Programs U.S. – Europe CentricNorth America and Europe dominate as the site of pharma Medical Education programs. However,emerging regions are sure to see an increase in programs given the growing sales in those markets.In 2010, emerging Asia Pacific accounted for 17 percent of GSK’s, 18 percent of Pfizer’s and 30percent of Sanofi’s revenues. Emerging regions present a clear opportunity for education programs. Regional Program Deployment: Estimate the percentage of your total medical education programs in the last 12 months deployed across the following regions. Pharmaceutical Segment Max Mean Min 100% 100% 80.60% 25% 20% 20% 20% 12.90% 5% 2.20% 1.40% 1.40% 1.20% 0.20% 0% 0% 0% 0% 0% 0% 0% North America Europe Asia-Pacific Asia-Emerging Latin America Eastern Europe Rest of World (US / Canada) (Japan, (China, India, (Mexico, Australia, New Southeast Asia) Caribbean, Zealand) Central &N=21 South America) 14 Copyright© Best Practices®, LLC
  15. 15. Pharma Relies on Technology for ProgramsOn-demand Medical Education programs have proven popular in both pharma anddevice sectors as they offer busy physicians the flexibility to choose their timing foreducation. On-demand and online Webcasts will continue to grow because of theirconvenience. Using Technology for Program Deployment: Estimate the percent of various deployment approaches used for delivering your medical education programs in your last fiscal year. Pharmaceutical Segment Site-hosted Simulations, Online Downloadable Videos / Other, 17.3% On-Demand Online Live Podcasts, Channels on 4.5% Online On- Programs webcasts Case studies YouTube Simulations Other Site-hosted DemandMax 100% 100% 80% 25% 30% 90% Programs, Videos /75th Percentile 50% 32.5% 20% 10% 2.8% 21.3% Channels on 32.3% YouTube,Mean 32.3% 25.8% 14.7% 5.5% 4.5% 17.3% 5.5%Median 22.5% 20% 10% 1% 0% 1% Download- Online Live25th Percentile 10% 4% 2.3% 0% 0% 0% able webcasts, Podcasts, 25.8%Min 0% 0% 0% 0% 0% 0% Case studies, 14.7%N=20 15 Copyright© Best Practices®, LLC
  16. 16. Professional Medical Education Excellence: Budget Benchmarks & Allocation Trends 16 Copyright© Best Practices®, LLC
  17. 17. Pharma MedEd Budget Mostly for Grants & ProgramsEducation grants and programs make up most of the Medical Education budgets in pharma.With fewer FTEs allocated to education in pharma, the percentage of budget dedicated to staffis less. As some of large pharma has stepped away from education because of controversyand perception issues, FTEs and program support have gone down. Investment Allocations: Please estimate the percentage of your annual budget that is invested in these key areas. Pharmaceutical Segment Training Education Infra- Training Infra- Centers, Grants Programs FTEs Fellowships structure Centers structure, 2.3%Max 100% 96% 60% 20% 35% 30% 3.8% Fellowships,75th Percentile 85.3% 42.5% 18.8% 5% 4.3% 0% 4.2%Mean 53.4% 23.9% 12.4% 4.2% 3.8% 2.3% FTEs, 12.4% Grants,Median 67.5% 1.5% 6.5% 1% 0% 0% 53.4%25th Percentile 17.5% 0% 0% 0% 0% 0% EducationMin 0% 0% 0% 0% 0% 0% Programs, 23.9% N=18 17 Copyright© Best Practices®, LLC
  18. 18. Pharma Sees Web Programs Leading Tech SpendingWeb-based education programs will dominate technology budgets over the next twoyears, pharma participants said. Technology Spending: Looking forward over the next 24 months, what percentage of your technology budget do you foresee being spent on the following technologies? Pharmaceutical Segment Site-hosted Videos/ Hand-held Web-based Tablets/ Channels devices/ Programs iPads Podcasts on YouTube Smartphone Other Hand-held devices/ Other, 15.1%Max 90% 50% 40% 50% 25% 100% Smartphone,75th Percentile 67.5% 23.8% 10% 10% 10% 7.8% 7.3%Mean 46.5% 15.8% 8.1% 7.3% 7.3% 15.1% Site-hosted Web-based Videos/ Programs,Median 50% 10% 2.5% 0.5% 3% 0% Channels on 46.5%25th Percentile 32.5% 6.3% 0% 0% 0% 0% YouTube, 7.3%Min 0% 0% 0% 0% 0% 0% Podcasts, Tablets/ 8.1% Ipads, 15.8% N=18 18 Copyright© Best Practices®, LLC
  19. 19. About Best Practices, LLC & Contact Info Best Practices, LLC is a research and consulting firm that conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. Best Practices, LLC offers innovative research, consulting, databases, membership and advisory services for bio-pharma and medical device Intelligence leaders who want to use best practice approaches to improve performance, solve problems and drive success in their own organizations. Best Practices, LLC 919-403-0251 6350 Quadrangle Drive, Suite 200, Chapel Hill, NC 27517 19 Copyright© Best Practices®, LLC